Next Article in Journal
Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
Next Article in Special Issue
The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
Previous Article in Journal
Syncope in a Working-Age Population: Recurrence Risk and Related Risk Factors
Previous Article in Special Issue
Evidence for a Common Genetic Origin of Classic and Milder Adult-Onset Forms of Isolated Hypogonadotropic Hypogonadism
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
J. Clin. Med. 2019, 8(2), 151; https://doi.org/10.3390/jcm8020151

Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation

1
Department of Urology, Men’s Health Clinic, Inje University, Seoul Paik Hospital, Seoul 04551, Korea
2
Department of Urology, Inje University, Seoul Paik Hospital, Seoul 04551, Korea
3
Department of Clinical Laboratory Science, Daejeon Health Institute of Technology, Daejeon 34504, Korea
4
Department of Urology, National Medical Center, Seoul 04564, Korea
5
Department of Urology, Korea University, Guro Hospital, Seoul 08308, Korea
*
Author to whom correspondence should be addressed.
Received: 6 January 2019 / Revised: 17 January 2019 / Accepted: 28 January 2019 / Published: 29 January 2019
(This article belongs to the Special Issue Testosterone and Men’s Health: From Evidence to Clinical Practice)
Full-Text   |   PDF [373 KB, uploaded 26 February 2019]   |  

Abstract

There is no conclusive evidence as to whether patients with testosterone deficiency (TD) who benefit from testosterone treatment (TRT) must continue the treatment for the rest of their lives. In some patients, the effect of TRT does not maintained after stopping TRT and, some patients show no significant TD symptoms, with normal testosterone levels after TRT cessation. Therefore, we investigated the predictive factors of response maintenance after TRT cessation. A total of 151 men with TD who responded to TRT were followed up for six months after TRT discontinuation. Ninety-two patients (Group I) failed to show response maintenance; 59 patients (Group II) had a maintained response. The groups did not differ in baseline characteristics or the type of TRT (oral, gel, short/long-acting injectables). However, TRT duration was significantly longer (10.7 vs. 5.2 months), and peak total testosterone (TT) level was significantly higher (713.7 vs. 546.1 ng/dL), in Group II than in Group I. More patients regularly exercised in Group II than in Group I (45.8% vs. 9.8%, p < 0.001). A multivariate logistic regression analysis revealed that exercise (B = 2.325, odds ratio = 10.231, p < 0.001) and TRT duration (B = 0.153, Exp(B) = 1.166, p < 0.001) were independent predictive factors of response maintenance. In men with TD who respond to TRT, longer treatment periods can improve the response durability after TRT cessation, regardless of the type of TRT. Additionally, regular exercise can increase the probability of maintaining the response after TRT cessation. View Full-Text
Keywords: testosterone; testosterone deficiency; testosterone replacement therapy; response maintenance testosterone; testosterone deficiency; testosterone replacement therapy; response maintenance
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Park, M.G.; Yeo, J.K.; Park, S.G.; Na, W.; Moon, D.G. Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation. J. Clin. Med. 2019, 8, 151.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top